Traws Pharma, Inc. (TRAW) has 13 known insider and institutional holders on record. The largest holder is Dukes Iain D. with 231,336 shares. Other notable holders include Greenwood Luba and Pauza Charles David.
Over the last 12 months, insiders have made 33 transactions in TRAW stock — 32 buys (valued at $2.83M) and 0 sells (valued at RSU Award). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.
TRAW Insider Ownership
Top Holder
Dukes Iain D.
231,336 shares
Buys (12 mo)
32
$2.83M value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Dukes Iain D. |
Chief Executive Officer |
231,336 |
2026-03-10 |
|
| 2 |
Greenwood Luba |
Director |
164,000 |
2024-09-17 |
|
| 3 |
Pauza Charles David |
Chief Science Officer Virology |
118,367 |
2026-03-10 |
|
| 4 |
Redfield Robert |
Chief Medical Officer |
108,854 |
2026-03-10 |
|
| 5 |
Savchuk Nikolay |
Chief Operating Officer |
96,899 |
2026-03-10 |
|
| 6 |
Tpav, Llc |
10 Percent Owner |
96,348 |
2025-01-27 |
|
| 7 |
Orbimed Advisors Llc |
10 Percent Owner |
96,348 |
2025-01-27 |
|
| 8 |
Guerin Mark Patrick |
CFO |
41,476 |
2024-06-20 |
|
| 9 |
Stover Jack E |
Director |
33,435 |
2026-03-10 |
|
| 10 |
Leaman John Harold |
Director |
33,435 |
2026-03-10 |
|
| 11 |
Shoemaker Mary Teresa |
Director |
33,435 |
2026-03-10 |
|
| 12 |
Clarke Trafford |
Director |
33,435 |
2026-03-10 |
|
| 13 |
Cautreels Werner |
Director |
31,258 |
2026-03-10 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-03-08 |
Redfield Robert |
Chief Medical Officer |
RSU Award |
108,854 |
$1.60 |
$174.17K |
| 2026-03-08 |
Pauza Charles David |
Chief Science Officer Virology |
RSU Award |
118,367 |
$1.60 |
$189.39K |
| 2026-03-08 |
Savchuk Nikolay |
Chief Operating Officer |
RSU Award |
96,899 |
$1.60 |
$155.04K |
| 2026-03-08 |
Clarke Trafford |
Director |
RSU Award |
33,435 |
$1.60 |
$53.5K |
| 2026-03-08 |
Shoemaker Mary Teresa |
Director |
RSU Award |
33,435 |
$1.60 |
$53.5K |
| 2026-03-08 |
Dukes Iain D. |
Chief Executive Officer |
RSU Award |
231,336 |
$1.60 |
$370.14K |
| 2026-03-08 |
Leaman John Harold |
Director |
RSU Award |
33,435 |
$1.60 |
$53.5K |
| 2026-03-08 |
Cautreels Werner |
Director |
RSU Award |
31,258 |
$1.60 |
$50.01K |
| 2026-03-08 |
Stover Jack E |
Director |
RSU Award |
33,435 |
$1.60 |
$53.5K |
| 2025-12-12 |
Redfield Robert |
Chief Medical Officer |
RSU Award |
65,676 |
$2.33 |
$153.03K |
| 2025-12-12 |
Pauza Charles David |
Chief Science Officer Virology |
RSU Award |
73,886 |
$2.33 |
$172.15K |
| 2025-12-12 |
Savchuk Nikolay |
Chief Operating Officer |
RSU Award |
65,676 |
$2.33 |
$153.03K |
| 2025-12-12 |
Clarke Trafford |
Director |
RSU Award |
6,157 |
- |
- |
| 2025-12-12 |
Shoemaker Mary Teresa |
Director |
RSU Award |
6,157 |
- |
- |
| 2025-12-12 |
Dukes Iain D. |
Chief Executive Officer |
RSU Award |
147,771 |
$2.33 |
$344.31K |
| 2025-12-12 |
Leaman John Harold |
Director |
RSU Award |
4,058 |
- |
- |
| 2025-12-12 |
Cautreels Werner |
Director |
RSU Award |
19,496 |
$2.33 |
$45.43K |
| 2025-12-12 |
Stover Jack E |
Director |
RSU Award |
6,157 |
- |
- |
| 2025-11-21 |
Leaman John Harold |
Director |
RSU Award |
12,770 |
$2.31 |
$29.5K |
| 2025-10-12 |
Redfield Robert |
Chief Medical Officer |
RSU Award |
32,406 |
$3.01 |
$97.54K |
| 2025-10-12 |
Pauza Charles David |
Chief Science Officer Virology |
RSU Award |
32,406 |
$3.01 |
$97.54K |
| 2025-10-12 |
Savchuk Nikolay |
Chief Operating Officer |
RSU Award |
22,435 |
$3.01 |
$67.53K |
| 2025-10-12 |
Clarke Trafford |
Director |
RSU Award |
11,530 |
$3.01 |
$34.71K |
| 2025-10-12 |
Shoemaker Mary Teresa |
Director |
RSU Award |
11,530 |
$3.01 |
$34.71K |
| 2025-10-12 |
Dukes Iain D. |
Chief Executive Officer |
RSU Award |
64,839 |
$3.01 |
$195.17K |
